Continuous glucose monitors add five hours a day in healthy blood sugar range for type 2 diabetes

· Health · United States

Continuous glucose monitors could transform diabetes management for millions of Americans with type 2 diabetes who do not take insulin, according to findings published in the New England Journal of Medicine. Patients using the devices spent about five more hours a day within a healthy blood sugar range, the study reported. CGMs, which track glucose levels continuously through a sensor rather than intermittent finger-stick tests, have until now been most associated with insulin-dependent patients. The results extend the evidence base to a much larger group of people with type 2 diabetes who manage the condition without insulin. Wider adoption could affect device makers and payers, as well as clinical guidance on how the technology is prescribed.

Why it matters：Evidence supporting CGMs in non-insulin type 2 patients could widen reimbursement and prescribing far beyond the insulin-dependent market, a significant expansion for diabetes device makers.

Key points

  • Findings were published in the New England Journal of Medicine.
  • The benefit was measured in additional hours per day in a healthy glucose range.
  • The study covered people with type 2 diabetes who do not take insulin.

Sources (original reporting)

More stories from this day